Leishmaniasis: Drugs in the clinic, resistance and new developments

Drug Resistance Updates

Volumn 7, Issue 4-5, 2004, Pages 257-266

  Ouellette, Marc ^a   Drummelsmith, Jolyne ^a   Papadopoulou, Barbara ^a  

^a UNIVERSITÉ LAVAL   (Canada)

Author keywords

ABC transporters; Amphotericin B; Fluconazole; Glucantime; Kala azar; Leishmania; Leishmaniasis; Meglumine antimoniate; Miltefosine; Pentamidine; Pentavalent antimonials; Pentostam; Stibogluconate

Indexed keywords

ABC TRANSPORTER; AMPHOTERICIN B; ANTILEISHMANIAL AGENT; ANTIMONY; BUTHIONINE SULFOXIMINE; CARRIER PROTEIN; EFLORNITHINE; ITRACONAZOLE; KETOCONAZOLE; MEGLUMINE ANTIMONATE; MILTEFOSINE; PAROMOMYCIN; PENTAMIDINE; SITAMAQUINE; STIBOGLUCONATE SODIUM; TERBINAFINE; THIOL DERIVATIVE; VERAPAMIL;

CLINICAL TRIAL; DIABETES MELLITUS; DRUG MECHANISM; DRUG SENSITIVITY; DRUG TRANSPORT; HUMAN; HYPOGLYCEMIA; HYPOTENSION; LEISHMANIA; LEISHMANIASIS; NEPHROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROTOZOAL GENETICS; REVIEW;

EID: 7944237421     PISSN: 13687646     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.drup.2004.07.002     Document Type: Article

References (107)

1. A.A. Alrajhi, E.A. Ibrahim, E.B. De Vol, M. Khairat, R.M. Faris, and J.H. Maguire Fluconazole for the treatment of cutaneous leishmaniasis caused by Leishmania major N. Engl. J. Med. 346 2002 891 895
2. F.E. Arana, J.M. Perez-Victoria, Y. Repetto, A. Morello, S. Castanys, and F. Gamarro Involvement of thiol metabolism in resistance to glucantime in Leishmania tropica (in process citation) Biochem. Pharmacol. 56 1998 1201 1208
3. M. Basselin, G.H. Coombs, and M.P. Barrett Putrescine and spermidine transport in Leishmania Mol. Biochem. Parasitol. 109 2000 37 46
4. M. Basselin, H. Denise, G.H. Coombs, and M.P. Barrett Resistance to pentamidine in Leishmania mexicana involves exclusion of the drug from the mitochondrion Antimicrob. Agents Chemother. 46 2002 3731 3738
5. J. Berman Current treatment approaches to leishmaniasis Curr. Opin. Infect. Dis. 16 2003 397 401
6. S.M. Beverley Gene amplification in Leishmania Annu. Rev. Microbiol. 45 1991 417 444
7. P. Borst, and R.O. Elferink Mammalian ABC transporters in health and disease Annu. Rev. Biochem. 71 2002 537 592
8. Brochu, C., Haimeur, A., Ouellette, M., in press. The heat shock protein HSP70 and heat shock cognate protein HSC70 contribute to antimony tolerance in the protozoan parasite Leishmania. Cell Stress Chaperones.
9. C. Brochu, J. Wang, G. Roy, N. Messier, X.Y. Wang, N.G. Saravia, and M. Ouellette Antimony uptake systems in the protozoan parasite Leishmania and accumulation differences in antimony-resistant parasites Antimicrob. Agents Chemother. 47 2003 3073 3079
10. H.L. Callahan, and S.M. Beverley Heavy metal resistance: a new role for P-glycoproteins in Leishmania J. Biol. Chem. 266 1991 18427 18430
11. H.L. Callahan, A.C. Portal, R. Devereaux, and M. Grogl An axenic amastigote system for drug screening Antimicrob. Agents Chemother. 41 1997 818 822
12. J. Carrio, M. de Colmenares, C. Riera, M. Gallego, M. Arboix, and M. Portus Leishmania infantum: stage-specific activity of pentavalent antimony related with the assay conditions Exp. Parasitol. 95 2000 209 214
13. K.C. Carter, A.B. Mullen, S. Sundar, and R.T. Kenney Efficacies of vesicular and free sodium stibogluconate formulations against clinical isolates of Leishmania donovani Antimicrob. Agents Chemother. 45 2001 3555 3559
14. K.C. Carter, S. Sundar, C. Spickett, O.C. Pereira, and A.B. Mullen The in vivo susceptibility of Leishmania donovani to sodium stibogluconate is drug specific and can be reversed by inhibiting glutathione biosynthesis Antimicrob. Agents Chemother. 47 2003 1529 1535
15. CDC Update: cutaneous leishmaniasis in U.S. military personnel - Southwest/Central Asia, 2002-2004 Morb. Mortal. Wkly. Rep. 53 2004 264 265
16. Z.S. Chen, M. Mutoh, T. Sumizawa, T. Furukawa, M. Haraguchi, A. Tani, and S. Akiyama Reversal of heavy metal resistance in multidrug-resistant human KB carcinoma cells Biochem. Biophys. Res. Commun. 236 1997 586 590
17. A.C. Coelho, S.M. Beverley, and P.C. Cotrim Functional genetic identification of PRP1, an ABC transporter superfamily member conferring pentamidine resistance in Leishmania major Mol. Biochem. Parasitol. 130 2003 83 90
18. S.P. Cole, K.E. Sparks, K. Fraser, D.W. Loe, C.E. Grant, G.M. Wilson, and R.G. Deeley Pharmacological characterization of multidrug resistant MRP-transfected human tumor cells Cancer Res. 54 1994 5902 5910
19. P.C. Cotrim, L.K. Garrity, and S.M. Beverley Isolation of genes mediating resistance to inhibitors of nucleoside and ergosterol metabolism in Leishmania by overexpression/selection J. Biol. Chem. 274 1999 37723 37730
20. S.L. Croft, and G.H. Coombs Leishmaniasis - current chemotherapy and recent advances in the search for novel drugs Trends Parasitol. 19 2003 502 508
21. S.L. Croft, R.A. Neal, W. Pendergast, and J.H. Chan The activity of alkyl phosphorylcholines and related derivatives against Leishmania donovani Biochem. Pharmacol. 36 1987 2633 2636
22. S.L. Croft, K.D. Neame, and C.A. Homewood Accumulation of [125Sb]sodium stibogluconate by Leishmania mexicana amazonensis and Leishmania donovani in vitro Comp. Biochem. Physiol. C 68C 1981 95 98
23. A.J. Davis, H.W. Murray, and E. Handman Drugs against leishmaniasis: a synergy of technology and partnerships Trends Parasitol. 20 2004 73 76
24. A. Debrabant, N. Lee, S. Bertholet, R. Duncan, and H.L. Nakhasi Programmed cell death in trypanosomatids and other unicellular organisms Int. J. Parasitol. 33 2003 257 267
25. H. Denton, J.C. McGregor, and G.H. Coombs Reduction of antileishmanial pentavalent antimonial drugs by a parasite-specific thiol dependent reductase TDR1 Biochem. J. 1 2004
26. S. Dey, M. Ouellette, J. Lightbody, B. Papadopoulou, and B.P. Rosen An ATP-dependent As(III)-glutathione transport system in membrane vesicles of Leishmania tarentolae Proc. Natl. Acad. Sci. U.S.A. 93 1996 2192 2197
27. S. Dey, B. Papadopoulou, A. Haimeur, G. Roy, K. Grondin, D. Dou, B.P. Rosen, and M. Ouellette High level arsenite resistance in Leishmania tarentolae is mediated by an active extrusion system Mol. Biochem. Parasitol. 67 1994 49 57
28. M.A. Dodge, R.F. Waller, L.M. Chow, M.M. Zaman, L.M. Cotton, M.J. McConville, and D.F. Wirth Localization and activity of multidrug resistance protein 1 in the secretory pathway of Leishmania parasites Mol. Microbiol. 51 2004 1563 1575
29. J. Drummelsmith, V. Brochu, I. Girard, N. Messier, and M. Ouellette Proteome mapping of the protozoan parasite Leishmania and application to the study of drug targets and resistance mechanisms Mol. Cell Proteomics 2 2003 146 155
30. M. Enserink Infectious diseases. Has leishmaniasis become endemic in the US? Science 290 2000 1881 1883
31. M. Ephros, A. Bitnun, P. Shaked, E. Waldman, and D. Zilberstein Stage-specific activity of pentavalent antimony against Leishmania donovani axenic amastigotes Antimicrob. Agents Chemother. 43 1999 278 282
32. A.H. Fairlamb, and A. Cerami Metabolism and functions of trypanothione in the Kinetoplastida Annu. Rev. Microbiol. 46 1992 695 729
33. F. Faraut-Gambarelli, R. Piarroux, M. Deniau, B. Giusiano, P. Marty, G. Michel, B. Faugere, and H. Dumon In vitro and in vivo resistance of Leishmania infantum to meglumine antimoniate: a study of 37 strains collected from patients with visceral leishmaniasis Antimicrob. Agents Chemother. 41 1997 827 830
34. K.C. Ferreira-Pinto, A.L. Miranda-Vilela, C. Anacleto, A.P. Fernandes, M.C. Abdo, M.L. Petrillo-Peixoto, and E.S. Moreira Leishmania (V.) guyanensis: isolation and characterization of glucantime-resistant cell lines Can. J. Microbiol. 42 1996 944 949
35. D. Fong, M.M. Chan, R. Rodriguez, L.J. Gately, J.D. Berman, and M. Grogl Paromomycin resistance in Leishmania tropica: lack of correlation with mutation in the small subunit ribosomal RNA gene Am. J. Trop. Med. Hyg. 51 1994 758 766
36. L.J. Goad, G.G. Holz, and D.H. Beach Sterols of Leishmania species. Implications for biosynthesis. Mol. Biochem. Parasitol. 10 1984 161 170
37. B. Gourbal, N. Sonuc, H. Bhattacharjee, D. Legare, S. Sundar, M. Ouellette, B.P. Rosen, and R. Mukhopadhyay Drug uptake and modulation of drug resistance in Leishmania by an aquaglyceroporin J. Biol. Chem. 279 2004 31010 31017
38. K. Grondin, A. Haimeur, R. Mukhopadhyay, B.P. Rosen, and M. Ouellette Co-amplification of the gamma-glutamylcysteine synthetase gene gsh1 and of the ABC transporter gene pgpA in arsenite-resistant Leishmania tarentolae EMBO J. 16 1997 3057 3065
39. K. Grondin, G. Roy, and M. Ouellette Formation of extrachromosomal circular amplicons with direct or inverted duplications in drug-resistant Leishmania tarentolae Mol. Cell. Biol. 16 1996 3587 3595
40. P.J. Guerin, P. Olliaro, S. Sundar, M. Boelaert, S.L. Croft, P. Desjeux, M.K. Wasunna, and A.D. Bryceson Visceral leishmaniasis: current status of control, diagnosis, and treatment, and a proposed research and development agenda Lancet Infect. Dis. 2 2002 494 501
41. C. Guimond, N. Trudel, C. Brochu, N. Marquis, A.E. Fadili, R. Peytavi, G. Briand, D. Richard, N. Messier, B. Papadopoulou, J. Corbeil, M.G. Bergeron, D. Legare, and M. Ouellette Modulation of gene expression in Leishmania drug resistant mutants as determined by targeted DNA microarrays Nucleic Acids Res. 31 2003 5886 5896
42. A. Haimeur, C. Brochu, P. Genest, B. Papadopoulou, and M. Ouellette Amplification of the ABC transporter gene PGPA and increased trypanothione levels in potassium antimonyl tartrate (SbIII) resistant Leishmania tarentolae Mol. Biochem. Parasitol. 108 2000 131 135
43. A. Haimeur, G. Conseil, R.G. Deeley, and S.P. Cole The MRP-related and BCRP/ABCG2 multidrug resistance proteins: biology, substrate specificity and regulation Curr. Drug Metab. 5 2004 21 53
44. A. Haimeur, C. Guimond, S. Pilote, R. Mukhopadhyay, B.P. Rosen, R. Poulin, and M. Ouellette Elevated levels of polyamines and trypanothione resulting from overexpression of the ornithine decarboxylase gene in arsenite-resistant Leishmania Mol. Microbiol. 34 1999 726 735
45. A. Haimeur, and M. Ouellette Gene amplification in Leishmania tarentolae selected for resistance to sodium stibogluconate (in process citation) Antimicrob. Agents Chemother. 42 1998 1689 1694
46. S.W. Kamau, F. Grimm, and A.B. Hehl Expression of green fluorescent protein as a marker for effects of antileishmanial compounds in vitro Antimicrob. Agents Chemother. 45 2001 3654 3656
47. M. Kandpal, and B.L. Tekwani Polyamine transport systems of Leishmania donovani promastigotes Life Sci. 60 1997 1793 1801
48. G.M. Kapler, C.M. Coburn, and S.M. Beverley Stable transfection of the human parasite Leishmania major delineates a 30-kilobase region sufficient for extrachromosomal replication and expression Mol. Cell. Biol. 10 1990 1084 1094
49. G.D. Kruh, and M.G. Belinsky The MRP family of drug efflux pumps Oncogene 22 2003 7537 7552
50. C. Kündig, E. Leblanc, B. Papadopoulou, and M. Ouellette Role of the locus and of the resistance gene on gene amplification frequency in methotrexate resistant Leishmania tarentolae Nucleic Acids Res. 27 1999 3653 3659
51. N. Lee, S. Bertholet, A. Debrabant, J. Muller, R. Duncan, and H.L. Nakhasi Programmed cell death in the unicellular protozoan parasite Leishmania Cell Death Differ. 9 2002 53 64
52. D. Légaré, B. Papadopoulou, G. Roy, R. Mukhopadhyay, A. Haimeur, S. Dey, K. Grondin, C. Brochu, B.P. Rosen, and M. Ouellette Efflux systems and increased trypanothione levels in arsenite-resistant Leishmania Exp. Parasitol. 87 1997 275 282
53. D. Légaré, D. Richard, R. Mukhopadhyay, Y.D. Stierhof, B.P. Rosen, A. Haimeur, B. Papadopoulou, and M. Ouellette The Leishmania ABC protein PGPA is an intracellular metal-thiol transporter ATPase J. Biol. Chem. 276 2001 26301 26307
54. R. Lira, S. Sundar, A. Makharia, R. Kenney, A. Gam, E. Saraiva, and D. Sacks Evidence that the high incidence of treatment failures in Indian kala-azar is due to the emergence of antimony-resistant strains of Leishmania donovani J. Infect. Dis. 180 1999 564 567
55. J.R. Luque-Ortega, J.M. Saugar, C. Chiva, D. Andreu, and L. Rivas Identification of new leishmanicidal peptide lead structures by automated real-time monitoring of changes in intracellular ATP Biochem. J. 375 2003 221 230
56. H. Lux, N. Heise, T. Klenner, D. Hart, and F.R. Opperdoes Ether-lipid (alkyl-phospholipid) metabolism and the mechanism of action of ether-lipid analogues in Leishmania Mol. Biochem. Parasitol. 111 2000 1 14
57. M. Maarouf, M.T. Adeline, M. Solignac, D. Vautrin, and M. Robert-Gero Development and characterization of paromomycin-resistant Leishmania donovani promastigotes Parasite 5 1998 167 173
58. M. Maarouf, F. Lawrence, S. Brown, and M. Robert-Gero Biochemical alterations in paromomycin-treated Leishmania donovani promastigotes Parasitol. Res. 83 1997 198 202
59. M. Maarouf, F. Lawrence, S.L. Croft, and M. Robert-Gero Ribosomes of Leishmania are a target for the aminoglycosides Parasitol. Res. 81 1995 421 425
60. N. Mbongo, P.M. Loiseau, M.A. Billion, and M. Robert-Gero Mechanism of amphotericin B resistance in Leishmania donovani promastigotes Antimicrob. Agents Chemother. 42 1998 352 357
61. C.P. McHugh, M.L. Thies, P.C. Melby, L.D. Yantis Jr., R.W. Raymond, M.D. Villegas, and S.F. Kerr Short report: a disseminated infection of Leishmania mexicana in an eastern woodrat, Neotoma floridana, collected in Texas Am. J. Trop. Med. Hyg. 69 2003 470 472
62. A. Mehta, and C. Shaha Apoptotic death in Leishmania donovani promastigotes in response to respiratory chain inhibition: complex II inhibition results in increased pentamidine cytotoxicity J. Biol. Chem. 279 2004 11798 11813 (Epub 12003 Dec 11716)
63. A. Misslitz, J.C. Mottram, P. Overath, and T. Aebischer Targeted integration into a rRNA locus results in uniform and high level expression of transgenes in leishmania amastigotes (in process citation) Mol. Biochem. Parasitol. 107 2000 251 261
64. E. Moore, D. O'Flaherty, H. Heuvelmans, J. Seaman, H. Veeken, S. de Wit, and R.N. Davidson Comparison of generic and proprietary sodium stibogluconate for the treatment of visceral leishmaniasis in Kenya Bull. World Health Organ. 79 2001 388 393
65. R. Mukhopadhyay, S. Dey, N. Xu, D. Gage, J. Lightbody, M. Ouellette, and B.P. Rosen Trypanothione overproduction and resistance to antimonials and arsenicals in Leishmania Proc. Natl. Acad. Sci. U.S.A. 93 1996 10383 10387
66. H.W. Murray Clinical and experimental advances in treatment of visceral leishmaniasis Antimicrob. Agents Chemother. 45 2001 2185 2197
67. M. Ouellette, and P. Borst Drug resistance and P-glycoprotein gene amplification in the protozoan parasite Leishmania Res. Microbiol. 142 1991 737 746
68. M. Ouellette, and S. Ward Drug resistance in parasites J. Marr T. Nielsen R. Komuniecki Molecular Medical Parasitology 2002 Academic Press 395 430
69. B. Papadopoulou, G. Roy, S. Dey, B.P. Rosen, and M. Ouellette Contribution of the Leishmania P-glycoprotein-related gene ltpgpA to oxyanion resistance J. Biol. Chem. 269 1994 11980 11986
70. C. Paris, P.M. Loiseau, C. Bories, and J. Breard Miltefosine induces apoptosis-like death in Leishmania donovani promastigotes Antimicrob. Agents Chemother. 48 2004 852 859
71. M.K. Pathak, and T. Yi Sodium stibogluconate is a potent inhibitor of protein tyrosine phosphatases and augments cytokine responses in hemopoietic cell lines J. Immunol. 167 2001 3391 3397
72. F.J. Perez-Victoria, S. Castanys, and F. Gamarro Leishmania donovani resistance to miltefosine involves a defective inward translocation of the drug Antimicrob. Agents Chemother. 47 2003 2397 2403
73. F.J. Perez-Victoria, F. Gamarro, M. Ouellette, and S. Castanys Functional cloning of the miltefosine transporter. A novel P-type phospholipid translocase from Leishmania involved in drug resistance J. Biol. Chem. 278 2003 49965 49971 (Epub 42003 Sep 49927)
74. J.M. Perez-Victoria, F.J. Perez-Victoria, A. Parodi-Talice, I.A. Jimenez, A.G. Ravelo, S. Castanys, and F. Gamarro Alkyl-lysophospholipid resistance in multidrug-resistant leishmania tropica and chemosensitization by a novel P-glycoprotein-like transporter modulator Antimicrob. Agents Chemother. 45 2001 2468 2474
75. K. Ritmeijer, H. Veeken, Y. Melaku, G. Leal, R. Amsalu, J. Seaman, and R.N. Davidson Ethiopian visceral leishmaniasis: generic and proprietary sodium stibogluconate are equivalent; HIV co-infected patients have a poor outcome Trans. R. Soc. Trop. Med. Hyg. 95 2001 668 672
76. C.W. Roberts, R. McLeod, D.W. Rice, M. Ginger, M.L. Chance, and L.J. Goad Fatty acid and sterol metabolism: potential antimicrobial targets in apicomplexan and trypanosomatid parasitic protozoa Mol. Biochem. Parasitol. 126 2003 129 142
77. W.L. Roberts, and P.M. Rainey Antileishmanial activity of sodium stibogluconate fractions Antimicrob. Agents Chemother. 37 1993 1842 1846
78. W.L. Roberts, and P.M. Rainey Antimony quantification in Leishmania by electrothermal atomic absorption spectroscopy Anal. Biochem. 211 1993 1 6
79. B.P. Rosen Biochemistry of arsenic detoxification FEBS Lett. 529 2002 86 92
80. A.C. Rosypal, G.C. Troy, A.M. Zajac, R.B. Duncan Jr., K. Waki, K.P. Chang, and D.S. Lindsay Emergence of zoonotic canine leishmaniasis in the United States: isolation and immunohistochemical detection of Leishmania infantum from foxhounds from Virginia J. Eukaryot. Microbiol. 50 Suppl. 2003 691 693
81. G. Roy, C. Dumas, D. Sereno, Y. Wu, A.K. Singh, M.J. Tremblay, M. Ouellette, M. Olivier, and B. Papadopoulou Episomal and stable expression of the luciferase reporter gene for quantifying Leishmania spp. infections in macrophages and in animal models Mol. Biochem. Parasitol. 110 2000 195 206
82. C. Santos Ferreira, P.S. Martins, C. Demicheli, C. Brochu, M. Ouellette, and F. Frezard Thiol-induced reduction of antimony(V) into antimony(III): a comparative study with trypanothione, cysteinyl-glycine, cysteine and glutathione Biometals 16 2003 441 446
83. M. Segovia Leishmania gene amplification: a mechanism of drug resistance Ann. Trop. Med. Parasitol. 88 1994 123 130
84. K. Seifert, S. Matu, F. Javier Perez-Victoria, S. Castanys, F. Gamarro, and S.L. Croft Characterisation of Leishmania donovani promastigotes resistant to hexadecylphosphocholine (miltefosine) Int. J. Antimicrob. Agents 22 2003 380 387
85. D. Sereno, M. Cavaleyra, K. Zemzoumi, S. Maquaire, A. Ouaissi, and J.L. Lemesre Axenically grown amastigotes of Leishmania infantum used as an in vitro model to investigate the pentavalent antimony mode of action Antimicrob. Agents Chemother. 42 1998 3097 3102
86. D. Sereno, P. Holzmuller, I. Mangot, G. Cuny, A. Ouaissi, and J.L. Lemesre Antimonial-mediated DNA fragmentation in Leishmania infantum amastigotes Antimicrob. Agents Chemother. 45 2001 2064 2069
87. D. Sereno, G. Roy, J.L. Lemesre, B. Papadopoulou, and M. Ouellette DNA transformation of Leishmania infantum axenic amastigotes and their use in drug screening Antimicrob Agents Chemother. 45 2001 1168 1173
88. D. Sereno, and J.L. Lemesre Axenically cultured amastigote forms as an in vitro model for investigation of antileishmanial agents Antimicrob. Agents Chemother. 41 1997 972 976
89. P. Shaked-Mishan, N. Ulrich, M. Ephros, and D. Zilberstein Novel intracellular SbV reducing activity correlates with antimony susceptibility in Leishmania donovani J. Biol. Chem. 276 2001 3971 3976
90. A.K. Singh, B. Papadopoulou, and M. Ouellette Gene amplification in amphotericin B-resistant Leishmania tarentolae Exp. Parasitol. 99 2001 141 147
91. N. Singh, R.T. Singh, and S. Sundar Novel mechanism of drug resistance in kala azar field isolates J. Infect. Dis. 188 2003 600 607
92. G. Sudhandiran, and C. Shaha Antimonial-induced increase in intracellular Ca2+ through non-selective cation channels in the host and the parasite is responsible for apoptosis of intracellular Leishmania donovani amastigotes J. Biol. Chem. 278 2003 25120 25132 (Epub 22003 Apr 25121)
93. S. Sundar Drug resistance in Indian visceral leishmaniasis Trop. Med. Int. Health 6 2001 849 854
94. S. Sundar, L.B. Gupta, V. Rastogi, G. Agrawal, and H.W. Murray Short-course, cost-effective treatment with amphotericin B-fat emulsion cures visceral leishmaniasis Trans. R. Soc. Trop. Med. Hyg. 94 2000 200 204
95. S. Sundar, D.K. More, M.K. Singh, V.P. Singh, S. Sharma, A. Makharia, P.C. Kumar, and H.W. Murray Failure of pentavalent antimony in visceral leishmaniasis in India: report from the Center of the Indian Epidemic Clin. Infect. Dis. 31 2000 1104 1107
96. S. Sundar, T.K. Jha, C.P. Thakur, J. Engel, H. Sindermann, C. Fischer, K. Junge, A. Bryceson, and J. Berman Oral miltefosine for Indian visceral leishmaniasis N. Engl. J. Med. 347 2002 1739 1746
97. S. Sundar, H. Mehta, A.V. Suresh, S.P. Singh, M. Rai, and H.W. Murray Amphotericin B treatment for Indian visceral leishmaniasis: conventional versus lipid formulations Clin. Infect. Dis. 38 2004 377 383 (Epub 2004 Jan 2013)
98. S. Sundar, and M. Rai Advances in the treatment of leishmaniasis Curr. Opin. Infect. Dis. 15 2002 593 598
99. M.J. Tamas, and R. Wysocki Mechanisms involved in metalloid transport and tolerance acquisition Curr. Genet. 40 2001 2 12
100. C.P. Thakur, T.P. Kanyok, A.K. Pandey, G.P. Sinha, A.E. Zaniewski, H.H. Houlihan, and P. Olliaro A prospective randomized, comparative, open-label trial of the safety and efficacy of paromomycin (aminosidine) plus sodium stibogluconate versus sodium stibogluconate alone for the treatment of visceral leishmaniasis Trans. R. Soc. Trop. Med. Hyg. 94 2000 429 431
101. R. Tommasini, R. Evers, E. Vogt, C. Mornet, G.J. Zaman, A.H. Schinkel, P. Borst, and E. Martinoia The human multidrug resistance-associated protein functionally complements the yeast cadmium resistance factor 1 Proc. Natl. Acad. Sci. U.S.A. 93 1996 6743 6748
102. P. Trouiller, P. Olliaro, E. Torreele, J. Orbinski, R. Laing, and N. Ford Drug development for neglected diseases: a deficient market and a public health policy failure Lancet 359 2002 2188 2194
103. L. Vernhet, A. Courtois, N. Allain, L. Payen, J.P. Anger, A. Guillouzo, and O. Fardel Overexpression of the multidrug resistance-associated protein (MRP1) in human heavy metal-selected tumor cells FEBS Lett. 443 1999 321 325
104. Wyllie, S., Cunningham, M.L., Fairlamb, A.H., in press. Dual action of antimonial drugs on thiol redox metabolism in the human pathogen Leishmania donovani. J. Biol. Chem.
105. G.J. Zaman, J. Lankelma, O. van Tellingen, J. Beijnen, H. Dekker, C. Paulusma, R.P. Oude Elferink, F. Baas, and P. Borst Role of glutathione in the export of compounds from cells by the multidrug-resistance-associated protein Proc. Natl. Acad. Sci. U.S.A. 92 1995 7690 7694
106. H. Zangger, J.C. Mottram, and N. Fasel Cell death in Leishmania induced by stress and differentiation: programmed cell death or necrosis? Cell Death Differ. 9 2002 1126 1139
107. Y. Zhou, N. Messier, M. Ouellette, B.P. Rosen, and R. Mukhopadhyay Leishmania major LmACR2 is a pentavalent antimony reductase that confers sensitivity to the drug Pentostam J. Biol. Chem. 279 2004 37445 37451